Atnahs Pharma Denmark ApS: Financial statements 2018
CVR: 36699051
Source: annual report 2018, Danish Business Authority
01/04/2017 – 31/03/2018
Atnahs Pharma Denmark ApS (CVR 36699051) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -1,427,823 and a net result of DKK -1,858,350. Equity in the 2018 report amounted to DKK -1,309,496.
- Gross Profit
- DKK -1,427,823
- Profit/Loss
- DKK -1,858,350
- Equity
- DKK -1,309,496
- Total Assets
- DKK 7,217,639
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of February 28, 2018, is registered as an owner of Atnahs Pharma Denmark ApS with an ownership share of 100%.
About Atnahs Pharma Denmark ApS
Atnahs Pharma Denmark ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Pharmamentum ApS. The management consists of Christoph Michael Habereder. The board consists of Mohammad Muqtadir Samy (chair), Christoph Michael Habereder and Twan Johannes Anna Nouwen. The company is owned by Atnahs Pharma UK Limited. According to the 2026 annual report, the company had an average of 0 employees. In 2026, the company reported revenue of EUR 52,583,756 and a net result of EUR 12,487 compared with DKK 47,843 the year before. Equity in the 2026 report amounted to EUR 2,094,136.